Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel P…
4 months ago
finanznachrichten.de
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 A…
9 months ago
finanznachrichten.de
Immatics N.V. Provides Updated Dose Escalation Data from its Phase 1a Clinical Trial Evaluating its Second-Generation PRame Cell Therapy, IMA203CD8
Immatics N.V. Provides Updated Dose Escalation Data from its Pha…
3 months ago
marketscreener.com
Immatics : Deux candidats-médicaments affichent une bonne tolérabilité chez les patients atteints de tumeurs solides
Immatics : Deux candidats-médicaments affichent une bonne …
3 months ago
zonebourse.com
#cell2025 #lifescience #biotech #nextgenbiomed #celltherapy | Immatics
#cell2025 #lifescience #biotech #nextgenbiomed #celltherapy | Im…
4 months ago
linkedin.com
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phas…
Sep 16, 2024
finanznachrichten.de
Immatics shares early data on bispecific antibodies in Phase 1 trials | Dr. Timos Papagatsias posted on the topic | LinkedIn
Immatics shares early data on bispecific antibodies in Phase 1 tri…
3 months ago
linkedin.com
#cancer #immunotherapy #sitc #immunooncology #immunology …
Oct 4, 2024
linkedin.com
Immatics N.V. publie des données actualisées sur l'escalade de dos…
3 months ago
zonebourse.com
10:01
Hoffnungsträger (1) - immatics biotechnologies
Aug 27, 2014
n-tv.den-tv NACHRICHTEN
0:11
15 reactions | Proud to see the MACSQuant® Tyto® Cell Sorter is...
258 views3 weeks ago
FacebookMiltenyi Biotec
Immatics N.V. Provides Updated Data on the Phase 1a Dose Escala…
3 months ago
marketscreener.com
Immatics Announces Upcoming Oral Presentation at the Society fo…
Oct 11, 2024
finanznachrichten.de
1:04:03
Harpreet Singh, Immatics 🇩🇪 | PRAME, TCR Based Therapeutics | E20
1.2K viewsSep 2, 2024
YouTubeFlotBio x Philip Hemme
5:18
Immatics Therapeutic Approach
5.9K viewsAug 20, 2020
YouTubeImmatics
3:19
Immatics’ Clinical TCR Bispecifics (TCER®) Trials: A Patient’s Journey
1.2K viewsJul 5, 2022
YouTubeImmatics
Immatics’ Clinical ACTengine® TCR-T Trials: A Patient’s Journey
1.7K viewsApr 27, 2022
YouTubeImmatics
0:47
RTF.1-Nachrichten: Immatics und MorphoSys im Kampf gegen Krebs
77 viewsAug 26, 2015
YouTubeKlarnerMedien
1:01
Immatics on Instagram: "Today, we announced updated Phase 1a dos…
365 views3 months ago
Instagramimmatics
0:12
The only metter its that your tried #iamats #ltek #matology #interacti…
669 views2 months ago
Facebookiamats.com - Interactive Mats & More
55:59
ESMO 2025 Highlights: Key Uveal Melanoma Trial Updates with Dr. H…
1 month ago
YouTubeA Cure In Sight Ocular Melanoma
50:23
Understanding the Impact of MFN & Tariffs on the Cell & Gene Therap…
28 views2 months ago
YouTubeAlliance for Regenerative Medicine
2:17:42
5_4_Lesson 4 Section 4 iMMS
82 viewsJun 28, 2020
VimeoGiorgio Paolo Maria Vassena
XING
Jan 29, 2021
xing.com
0:32
Short-term Position Tracking with an IMU
73K viewsSep 16, 2010
YouTubeJames McNames
Gamma Delta T Cells: Ancient or New Path in Cancer Immunothera…
11 views1 week ago
linkedin.com
0:30
IMAnalytics V1.8
12 views4 months ago
YouTubeZurich MedTech AG
0:44
IM Tech | From precision on the test track to protection in real life — th…
594 views3 months ago
Instagramimmotors_tech_
8:00
IMS Architecture - A High-Level Explanation From Mpirical
40.9K viewsJul 18, 2017
YouTubeMpirical
See more videos
Static thumbnail place holder